ET Alpha Wealth Summit to Address Portfolio Resilience and Alpha Generation in Mumbai Nvidia Earnings in Focus Geopolitical Commentary Could Shape US Equities AI Adoption Faces Cost Hurdle Reports Suggest Technology May Be More Expensive Than Human Labor CapitaLand Unveils 14 Billion Life Sciences Hub Geneo to Transform Science Park Assurant AIZ Stock Outlook Wall Street Sentiment Remains Cautiously Optimistic Wall Street Analysts Set Sights on Paychex What Do Their Price Targets Indicate SENEA Q1 2026 Earnings Strong EPS of 619 Reported Amid Quiet Market Reaction BeyondSpring BYSI Q1 2026 Earnings Narrowing Loss and No Revenue as ClinicalStage Biotech Advances Pipeline AI Q1 2026 Earnings EPS Misses Estimates as Subscription Momentum Drives Stock Higher IDR Q1 2026 Earnings EPS Miss Weighs on Shares as Strategic Priorities Continue Union Pacific Corporation UNP Q1 2026 Earnings EPS Beat Amid Operational Efficiency Gains VVX Q1 2026 Earnings Strong EPS Beat of 475 Surprises Market AllianceBernstein AB Holds Steady Near 37 Amidst Modest Pullback Atrium Therapeutics Inc RNA Holds Steady Near Resistance as Momentum Builds LCNB Corporation Holds Steady Near Support as Market Awaits Direction New Germany Fund GF Slightly Lower as Price Hovers Near Support Levels Critical Metals Corp CRML Holds Steady Near Resistance After Slight Uptick Consumer Credit Growth Accelerates in December Signaling Economic Momentum BCML Q1 2026 Earnings Strong EPS Surprise Driven by Net Interest Income and Credit Quality Nauticus Robotics KITT Faces Renewed Selling Pressure as Price Tests Support MDLZ Q1 2026 Earnings EPS Beats Estimates by 81 as Snacking Giant Navigates Cost Pressures GRRR Q4 2025 Earnings Significant EPS Miss Despite Positive Stock Reaction BJDX Q4 2023 Earnings EPS Falls Far Below Estimates Revenue Remains Absent CRISPR Therapeutics Q1 2026 Earnings Slight EPS Miss as Clinical Pipeline Progresses CoreWeave Inc CRWV Q1 2026 Earnings EPS Misses Estimates Stock Declines Surrozen Inc SRZN Q1 2026 Earnings Significant EPS Miss Reflects Ongoing ClinicalStage Spending No Revenue Reported SSYS Q1 2026 Earnings Narrower Loss Surprises Market Shares Rally